MARCKS and mantle cell lymphoma: In conclusion, our work identified a set of six differentially expressed biomarkers for MCL and CLL, and among them, MARCKS to be differentially expressed, localized and phosphorylated between MCL and CLL, this being partly controlled by oncogenic microRNA miR-155.